Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotine

Biochemical Pharmacology

Volumn 86, Issue 8, 2013, Pages 1084-1088

  Dong, Yu ^a   Dani, John A ^a,b   Blakely, Randy D ^c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Choline; Cocaine; Dopamine; Microdialysis; Nicotine; Transporter

Indexed keywords

CHOLINE; CHOLINE TRANSPORTER; COCAINE; DOPAMINE; NICOTINE; PROTEIN; SLC5A7 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEMIZYGOSITY; HETEROZYGOSITY; IN VIVO STUDY; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84885584565     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.07.019     Document Type: Article

References (56)

1. Kasa P. The cholinergic systems in brain and spinal cord. Progress in Neurobiology 1986;26:211-72. (Pubitemid 16123343)
2. Woolf NJ. Cholinergic systems in mammalian brain and spinal cord. Progress in Neurobiology 1991;37:475-524.
3. Changeux JP, Edelstein SJ. Nicotinic acetylcholine receptors: from molecular biology to cognition. New York, NY: Odile Jacob Publishing Corp.; 2005.
4. De Biasi M. Nicotinic receptor mutant mice in the study of autonomic function. Current Drug Targets-CNS & Neurological Disorders 2002;1:331-6.
5. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 2007;47:699-729.
6. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological Reviews 2009;89:73-120.
7. Harper CM. Congenital myasthenic syndromes. Seminars in Neurology 2004;24:111-23. (Pubitemid 38823785)
8. Spillane J, Higham E, Kullmann DM. Myasthenia gravis. BMJ 2012;345:e8497.
9. Mitolo-Chieppa D, Mansi G, Rinaldi R, Montagnani M, Potenza MA, Genualdo M, et al. Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation. Digestive Diseases and Sciences 1998;43:2719-26. (Pubitemid 29034927)
10. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Matsui T, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-Term cardiovascular events in suspected coronary artery disease. Circulation Journal 2006;70:49-56. (Pubitemid 43021234)
11. Kaur-Knudsen D, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study. Journal of Clinical Oncology 2011;29:2875-82.
12. English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, et al. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. Journal of Neurodevelopmental Disorders 2009;1:252-63.
13. Williams MJ, Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008;33:1779-97. (Pubitemid 351832599)
14. De Biasi M, Dani JA. Reward addiction, withdrawal to nicotine. Annual Review of Neuroscience 2011;34:105-30.
15. Dani JA, Kosten TR, Benowitz NL. The pharmacology of nicotine and tobacco. In: Ries RK, Fiellin DA, Miller SC, Saitz R, editors. Principles of addiction medicine. Philadelphia, PA: Lippincott Williams & Wilkins, Wolters Kluwer; 2009. p. 179-91.
16. Blusztajn JK. Choline a vital amine. Science 1998;281:794-5.
17. Yamamura HI, Snyder SH. Choline: high-Affinity uptake by rat brain synaptosomes. Science 1972;178:626-8.
18. Apparsundaram S, Ferguson SM, George Jr. AL, Blakely RD. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochemical and Biophysical Research Communications 2000;276:862-7.
19. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, et al. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. Journal of Neuroscience 2003;23:9697-709. (Pubitemid 37371582)
20. Nakata K, Okuda T, Misawa H. Ultrastructural localization of high-Affinity choline transporter in the rat neuromuscular junction: enrichment on synaptic vesicles. Synapse 2004;53:53-6. (Pubitemid 38703005)
21. Ferguson SM, Blakely RD. The choline transporter resurfaces: new roles for synaptic vesicles. Molecular Interventions 2004;4:22-37. (Pubitemid 38702122)
22. Birks RI, Macintosh FC, Sastry PB. Pharmacological inhibition of acetylcholine synthesis. Nature 1956;178:1181.
23. Mulder AH, Yamamura HI, Kuhar MJ, Snyder SH. Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake. Brain Research 1974;70:372-6.
24. Schueler FW. A new group of respiratory paralyzants. I. The hemicholiniums. Journal of Pharmacology and Experimental Therapeutics 1955;115:127-43.
25. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2004;101:8762-7. (Pubitemid 38745845)
26. Barwick KE, Wright J, Al-Turki S, McEntagart MM, Nair A, Chioza B, et al. Defective presynaptic choline transport underlies hereditary motor neuropathy. American Journal of Human Genetics 2012;91:1103-7.
27. Lund D, Ruggiero AM, Ferguson SM, Wright J, English BA, Reisz PA, et al. Motor neuron-specific overexpressionof thepresynaptic choline transporter: impact on motor endurance and evokedmuscle activity. Neuroscience 2010;171:1041-53.
28. Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, et al. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain and Behavior 2007;6:411-24. (Pubitemid 47024956)
29. English BA, Appalsamy M, Diedrich A, Ruggiero AM, Lund D, Wright J, et al. Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. American Journal of Physiology -Heart and Circulatory Physiology 2010;299:H799-810.
30. Parikh V, St Peters M, Blakely RD, Sarter M. The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. Journal of Neuroscience 2013;33:2326-37.
31. Rand JB, Nonet ML. Synaptic transmission. In: Riddle DL, Blumenthal T, Meyer BJ, Priess JR, editors. C. elegans II. New York: Cold Spring Harbor Press; 1997. p. 611-43.
32. Matthies DS, Fleming PA, Wilkes DM, Blakely RD. The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis andmotor function in an activity-dependent manner. Journal of Neuroscience 2006;26:6200-12.
33. Dong Y, Zhang T, Li W, Doyon WM, Dani JA. Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion. Journal of Molecular Neuroscience 2010;40:164-71.
34. Zhang L, Dong Y, Doyon WM, Dani JA. Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biological Psychiatry 2012;71:184-91.
35. van Domburg PHMF, ten Donkelaar HJ. The human substantia nigra and ventral tegmental area. Advances in Anatomy Embryology and Cell Biology 1991.
36. Zhou FM, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neuroscience 2001;4:1224-9.
37. Zhang H, Sulzer D. Frequency-dependent modulation of dopamine release by nicotine. Nature Neuroscience 2004;7:581-2. (Pubitemid 38691893)
38. Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. Journal of Neuroscience 2009;29:4035-43.
39. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 2012;75:58-64.
40. McCormick DA. Actions of acetylcholine in the cerebral cortex and thalamus and implications for function. Progress in Brain Research 1993;98:303-8. (Pubitemid 23305661)
41. Sarter M, Bruno JP, Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Annals of the New York Academy of Sciences 1999;877:368-82. (Pubitemid 29351867)
42. Zhang D, Gao M, Xu D, Shi WX, Gutkin BS, Steffensen SC, et al. Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats. Journal of Neuroscience 2012;32:12366-75.
43. Hecker S, Mesulam MM. Two types of cholinergic projections to the rat amygdala. Neuroscience 1994;60:383-97. (Pubitemid 24175210)
44. Muller JF, Mascagni F, McDonald AJ. Cholinergic innervation of pyramidal cells and parvalbumin-immunoreactive interneurons in the rat basolateral amygdala. Journal of Comparative Neurology 2011;519:790-805.
45. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, et al. Distinct extended amygdala circuits for divergent motivational states. Nature 2013;496:224-8.
46. Brandon EP, Mellott T, Pizzo DP, Coufal N, D'Amour KA, Gobeske K, et al. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. Journal of Neuroscience 2004;24:5459-66. (Pubitemid 38812627)
47. Rice ME, Cragg SJ. Nicotine amplifies reward-related dopamine signals in striatum. Nature Neuroscience 2004;7:583-4. (Pubitemid 38691894)
48. Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annual Review of Neuroscience 2011;34:389-412.
49. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behavioral and Brain Functions 2010;6:24.
50. Rassadi S, Krishnaswamy A, Pie B, McConnell R, Jacob MH, Cooper E. A null mutation for the alpha3 nicotinic acetylcholine (ACh) receptor gene abolishes fast synaptic activity in sympathetic ganglia and reveals that ACh output from developing preganglionic terminals is regulated in an activity-dependent retrograde manner. Journal of Neuroscience 2005;25:8555-66. (Pubitemid 41324741)
51. Misgeld T, Burgess RW, Lewis RM, Cunningham JM, Lichtman JW, Sanes JR. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 2002;36:635-48. (Pubitemid 35346757)
52. de Castro BM, De Jaeger X, Martins-Silva C, Lima RD, Amaral E, Menezes C, et al. The vesicular acetylcholine transporter is required for neuromuscular development and function. Molecular and Cellular Biology 2009;29:5238-50.
53. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013;493:532-6.
54. Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, et al. Dopamine neurons modulate neural encoding and expression of depressionrelated behaviour. Nature 2013;493:537-41.
55. Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, et al. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety-And depression-like behavior. Proceedings of the National Academy of Sciences of the United States of America 2013;110:3573-8.
56. Paolone. et al. Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: A model of cholinergic capacity limits. Neuropharmacology 2013. in press.